GPD1
protein-codingglycerol-3-phosphate dehydrogenase 1
Gene summary
This gene encodes a member of the NAD-dependent glycerol-3-phosphate dehydrogenase family. The encoded protein plays a critical role in carbohydrate and lipid metabolism by catalyzing the reversible conversion of dihydroxyacetone phosphate (DHAP) and reduced nicotine adenine dinucleotide (NADH) to glycerol-3-phosphate (G3P) and NAD+. The encoded cytosolic protein and mitochondrial glycerol-3-phosphate dehydrogenase also form a glycerol phosphate shuttle that facilitates the transfer of reducing equivalents from the cytosol to mitochondria. Mutations in this gene are a cause of transient infantile hypertriglyceridemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013771
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013771
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0013771
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013771
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal
Intervention: Gastrointestinal
Rationale: Individuals may present with failure to thrive and other sequelae of disease, and dietary management (with high-calorie, low-fat diet) has been described as beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GPD1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005276.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 36 | 36 | ||||
| missense | 2 | 6 | 64 | 16 | 1 | 89 |
| nonsense | 3 | 2 | 1 | 6 | ||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 5 | 7 | |||
| splice donor/acceptor (+/-2bp) | 2 | 6 | 3 | 11 | ||
| Total | 9 | 19 | 69 | 52 | 1 | 150 |
Highest pathogenic variant AF is 0.00006506213
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005267.2 | 8 | MANE Select | |
| Ensembl | ENSP00000301149.3 | 8 | MANE Select | |
| RefSeq | NP_001244128.1 | 8 | Standard | |
| Ensembl | ENSP00000448244.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glycerophospholipid metabolism - Homo sapiens (human)
- Mitochondrial Electron Transport Chain
- Familial lipoprotein lipase deficiency
- Glycerol Phosphate Shuttle
- Glycerolipid Metabolism
Biological Process
- glycerol-3-phosphate metabolic process
- gluconeogenesis
- glycerophosphate shuttle
- phosphatidic acid biosynthetic process
- positive regulation of glycolytic process
Molecular Function
- glycerol-3-phosphate dehydrogenase [NAD+] activity
- glycerol-3-phosphate dehydrogenase (quinone) activity
- protein homodimerization activity
- glycerol-3-phosphate dehydrogenase [NAD(P)+] activity
- NAD binding
Cellular Component
- cytosol
- glycerol-3-phosphate dehydrogenase complex
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000301149
- Coding exons
- 8
- Length
- 7501
- Individuals with no LoFs
- 125700
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 48
- Defined
- 125748
- p
- 0.000191
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.167 | 199 | 206 | 0.967 | 0.0000117 | 2280 |
| Missense (PolyPhen) | 61 | 65.73 | 0.92804 | 741 | ||
| Synonymous | -0.507 | 88 | 82.2 | 1.07 | 0.00000494 | 690 |
| Loss of Function | 2.02 | 6 | 14.2 | 0.423 | 6.00e-7 | 179 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00018 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00022 | 0.00022 | rare |
| South Asian | 0.00033 | 0.00033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Disease
- DISEASE: Hypertriglyceridemia, transient infantile (HTGTI) [MIM:614480]: An autosomal recessive disorder characterized by onset of moderate to severe transient hypertriglyceridemia in infancy that normalizes with age. The hypertriglyceridemia is associated with hepatomegaly, moderately elevated transaminases, persistent fatty liver, and the development of hepatic fibrosis. {ECO:0000269|PubMed:22226083, ECO:0000269|PubMed:24549054}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.523
Intolerance Scores
- LoFtool
- 0.685
- RVIS EVS
- 0.15
- RVIS percentile EVS
- 64.61
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.996
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |